Genetic Technologies Limited (GTG.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.09 AUD | 24.25% |
| 2023 | -0.12 AUD | -55.24% |
| 2022 | -0.08 AUD | 6.64% |
| 2021 | -0.08 AUD | 44.8% |
| 2020 | -0.15 AUD | 34.78% |
| 2019 | -0.23 AUD | -4.55% |
| 2018 | -0.22 AUD | 45.0% |
| 2017 | -0.40 AUD | 18.37% |
| 2016 | -0.49 AUD | 40.24% |
| 2015 | -0.82 AUD | 53.41% |
| 2014 | -1.76 AUD | -9413.51% |
| 2013 | -0.02 AUD | -72.9% |
| 2012 | -0.01 AUD | -609.52% |
| 2011 | 0.00 AUD | 109.17% |
| 2010 | -0.02 AUD | 5.76% |
| 2009 | -0.02 AUD | -72.34% |
| 2008 | -0.01 AUD | -227.91% |
| 2007 | -0.00 AUD | 69.29% |
| 2006 | -0.01 AUD | 37.22% |
| 2005 | -0.02 AUD | 3.46% |
| 2004 | -0.02 AUD | -50.0% |
| 2003 | -0.02 AUD | 51.42% |
| 2002 | -0.03 AUD | -121.68% |
| 2001 | -0.01 AUD | -1488.89% |
| 2000 | -0.00 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 FY | - AUD | 17.08% |
| 2024 Q4 | -0.04 AUD | 0.0% |
| 2024 Q2 | -0.05 AUD | 0.0% |
| 2023 FY | - AUD | -55.24% |
| 2023 Q2 | -0.06 AUD | 0.0% |
| 2023 Q4 | -0.07 AUD | 0.0% |
| 2022 FY | - AUD | 6.64% |
| 2022 Q4 | -0.04 AUD | -17500.0% |
| 2022 Q1 | -0.00 AUD | 99.5% |
| 2022 Q2 | -0.04 AUD | -21000.0% |
| 2022 Q3 | -0.00 AUD | 99.53% |
| 2021 Q3 | -0.00 AUD | 99.53% |
| 2021 Q2 | -0.04 AUD | 0.0% |
| 2021 Q4 | -0.04 AUD | -20100.0% |
| 2021 FY | - AUD | 44.8% |
| 2020 FY | - AUD | 34.78% |
| 2020 Q2 | -0.08 AUD | 0.0% |
| 2020 Q4 | -0.07 AUD | 0.0% |
| 2019 FY | - AUD | -4.55% |
| 2019 Q4 | -0.11 AUD | 0.0% |
| 2019 Q2 | -0.12 AUD | 0.0% |
| 2018 Q4 | -0.09 AUD | 0.0% |
| 2018 FY | - AUD | 45.0% |
| 2018 Q2 | -0.14 AUD | 0.0% |
| 2017 Q2 | -0.22 AUD | 0.0% |
| 2017 Q4 | -0.19 AUD | 0.0% |
| 2017 FY | - AUD | 18.37% |
| 2016 FY | - AUD | 40.24% |
| 2016 Q4 | -0.24 AUD | 0.0% |
| 2016 Q2 | -0.25 AUD | 0.0% |
| 2015 Q4 | -0.28 AUD | 0.0% |
| 2015 FY | - AUD | 53.41% |
| 2015 Q2 | -0.69 AUD | 0.0% |
| 2014 Q4 | -0.78 AUD | 0.0% |
| 2014 FY | - AUD | -9413.51% |
| 2014 Q2 | -1.01 AUD | 0.0% |
| 2013 Q3 | - AUD | 100.0% |
| 2013 Q4 | -1.18 AUD | 0.0% |
| 2013 FY | - AUD | -72.9% |
| 2013 Q2 | -0.80 AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | -609.52% |
| 2012 Q2 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 FY | - AUD | 109.17% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 5.76% |
| 2009 FY | - AUD | -72.34% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 Q4 | -0.01 AUD | 99.0% |
| 2008 FY | - AUD | -227.91% |
| 2008 Q1 | -0.06 AUD | -1436.84% |
| 2008 Q2 | -0.06 AUD | 0.0% |
| 2008 Q3 | -0.64 AUD | -995.89% |
| 2007 Q4 | -0.00 AUD | -101.03% |
| 2007 FY | - AUD | 69.29% |
| 2007 Q3 | 0.37 AUD | 154.41% |
| 2007 Q2 | -0.68 AUD | 26.09% |
| 2007 Q1 | -0.92 AUD | -29577.42% |
| 2006 Q4 | -0.00 AUD | 99.14% |
| 2006 FY | - AUD | 37.22% |
| 2006 Q1 | -0.37 AUD | -21664.71% |
| 2006 Q2 | -0.40 AUD | -8.11% |
| 2006 Q3 | -0.36 AUD | 10.0% |
| 2005 Q3 | -1.99 AUD | -2297.59% |
| 2005 Q1 | -0.09 AUD | 0.0% |
| 2005 Q4 | -0.00 AUD | 99.91% |
| 2005 FY | - AUD | 3.46% |
| 2005 Q2 | -0.08 AUD | 7.05% |
| 2004 FY | - AUD | -50.0% |
| 2003 FY | - AUD | 51.42% |
| 2002 FY | - AUD | -121.68% |
| 2001 FY | - AUD | -1488.89% |
| 2000 FY | - AUD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Australian Clinical Labs Limited | 0.12 AUD | 175.75% |
| BCAL Diagnostics Limited | -0.03 AUD | -249.615% |
| Genetic Signatures Limited | -0.11 AUD | 17.364% |
| Healius Limited | -0.98 AUD | 90.724% |
| Imagion Biosystems Limited | -0.41 AUD | 77.829% |
| Integral Diagnostics Limited | -0.26 AUD | 65.038% |
| INOVIQ Ltd | -0.07 AUD | -28.209% |
| Microba Life Sciences Limited | -0.05 AUD | -87.037% |
| Monash IVF Group Limited | -0.02 AUD | -441.071% |
| Rhythm Biosciences Limited | -0.03 AUD | -203.0% |
| Sonic Healthcare Limited | 1.07 AUD | 108.495% |